A randomized comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions: Rationale and design of the PRImary Stenting of Occluded Native coronary arteries III (PRISON III) study

American Heart Journal

Volumn 154, Issue 3, 2007, Pages 432-435

  Suttorp, Maarten J ^a   Laarman, Gerrit J ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABT 578; RAPAMYCIN; UNCLASSIFIED DRUG; ZOTAROLIMUS;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SAFETY; SURVIVAL TIME; TREATMENT OUTCOME;

CORONARY DISEASE; DRUG DELIVERY SYSTEMS; HUMANS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SIROLIMUS; STENTS;

EID: 34548042329     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.04.041     Document Type: Article

References (21)

1. Sirnes P.A., Golf S., Myreng Y., et al. Stenting in chronic coronary occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 28 (1996) 1444-1451
2. Rubartelli P., Niccoli L., Verna E., et al. Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOC trial. J Am Coll Cardiol 32 (1998) 90-96
3. Buller C.E., Dzavik V., Carere R.G., et al. Primary stenting versus balloon angioplasty in occluded coronary arteries. The total occlusion study of Canada (TOSCA). Circulation 100 (1999) 236-242
4. Lotan C., Rozenman Y., Hendler A., et al. Stents in total occlusion for restenosis prevention. The multicenter randomized STOP study. Eur Heart J 21 (2000) 1960-1966
5. Höher M., Wöhrle J., Grebe O.C., et al. A randomized trial of elective stenting after balloon recanalization of chronic total occlusions. J Am Coll Cardiol 34 (1999) 722-729
6. Suttorp M.J., Mast E.G., Plokker H.W.M., et al. Primary coronary stenting after successful balloon angioplasty of chronic total occlusions: a single-center experience. Am Heart J 135 (1998) 318-322
7. Rahel B.M., Suttorp M.J., Laarman G.J., et al. Primary stenting of occluded native coronary arteries: final results of the PRISON I Study. Am Heart J 147 (2004) e22
8. Gallo R., Padurean A., Jayaraman T., et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 99 (1999) 2164-2170
9. Marx S.O., and Marks A.R. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 104 (2001) 852-855
10. Suzuki T., Kopia G., Hayashi S., et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104 (2001) 1188-1193
11. Rensing B.J., Vos J., Smits P.C., et al. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J 22 (2001) 2125-2130
12. Sousa J.E., Costa M.A., Abizaid A.C., et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 104 (2001) 2007-2011
13. Morice M.C., Serruys P.W., Sousa J.E., et al., for the RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
14. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
15. Meredith I.T., Ormiston J.A., Whitbourn R., et al. First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial. EuroIntervention 1 (2005) 157-164
16. Fajadet J., Wijns W., Laarman G.J., et al. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation 114 (2006) 798-806
17. Kandzari D., Leon M.B., Popma J.J., et al. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol 48 (2006) 2440-2447
18. Suttorp M.J., Laarman G.J., Rahel B.M., et al. Primary stenting of occluded native coronary arteries II (PRISON II). A randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation 114 (2006) 921-928
19. Lotan C., Algamor Y., Kuiper K., Suttorp M.J., and Wijns W. Sirolimus-eluting stent in chronic total occlusion: the SICTO study. J Interv Cardiol 19 (2006) 307-312
20. TIMI study group. The thrombolysis and myocardial infarction (TIMI) trial: phase I findings. N Engl J Med 318 (1988) 265-270
21. Dibra A., Kastrati A., Mehilli H., et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353 (2005) 663-670